DOCSLIB.ORG

Regulation of Mitochondrial Dynamics and Cell Fate Rimpy Dhingra, Phd; Lorrie A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulation of Mitochondrial Dynamics and Cell Fate Rimpy Dhingra, Phd; Lorrie A Advance Publication by-J-STAGE Circulation Journal REVIEW Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Regulation of Mitochondrial Dynamics and Cell Fate Rimpy Dhingra, PhD; Lorrie A. Kirshenbaum, PhD Though the mitochondrion was initially identified as a key organelle essentially required for energy production and oxidative metabolism, there is considerable evidence that mitochondria are intimately involved in regulating vital cellular processes, such as programmed cell death, proliferation and autophagy. Discovery of mitochondrial “shaping proteins” (Dynamin-related protein (Drp), mitofusins (Mfn) etc.) has revealed that mitochondria are highly dynamic organelles continually changing morphology by fission and fusion processes. Several human pathologies, including cancer, Parkinson’s disease, Alzheimer’s disease and cardiovascular diseases, have been linked to abnormalities in proteins that govern mitochondrial fission or fusion respectively. Notably, in the context of the heart, defects in mitochondrial dynamics resulting in too many fused and/or fragmented mitochondria have been associated with impaired cardiac development, autophagy, and contractile dysfunction. Understanding the mechanisms that govern mitochondrial fission/ fusion is paramount in developing new treatment strategies for human diseases in which defects in fission or fusion is the primary underlying defect. Here, we provide a comprehensive overview of the cellular targets and molecular signal- ing pathways that govern mitochondrial dynamics under normal and disease conditions. Key Words: Cell death; Drp1; Fission; Fusion; Mitochondrion ollowing the discovery of the mitochondrion in the mid- eases.4 In the context of the adult heart, the functional loss of 1800 s, there has been considerable interest over the cardiac myocytes by mitochondrial-driven programmed cell F past 100 years of biological research to understand death (apoptosis or necrosis) is postulated as an underlying how this remarkable organelle controls vital cellular processes cause of ventricular remodeling and heart failure.7 More recent such as energy metabolism, proliferation and cell death. Al- studies have implicated mitochondrial fission/fusion events in though mitochondria were first established as the “power autophagy/mitophagy during ischemic injury.8,9 In this review, house” of the cell, it was not until the mid-1970 s that they we will discuss the importance of mitochondrial dynamics and were appreciated for having cellular functions beyond their fusion/fission processes under normal and stress conditions original ascribed role in energy production.1 The concept that and the effect on cardiac function in particular. mitochondria contain the necessary signaling factors for initi- ating and executing programmed cell death was considered a major paradigm shift regarding their importance in regulating Mitochondrial Dynamics cell fate. Indeed, several lines of investigation have proposed Mitochondria are highly dynamic and plastic structures that are the mitochondrion as a central gateway for integrating signals continually changing morphology.10 Multiple proteins located for apoptosis, necrosis and autophagy.2 on the outer (OMM) and inner (IMM) mitochondrial mem- Though mitochondria were initially viewed as static organ- branes have been linked to mitochondrial fission/fusion. Fission elles, it is now well appreciated that they are dynamic struc- proteins include the cytosolic GTPase Dynamin-related pro- tures that move freely throughout the cell via dynamin motor tein-1 (Drp1),11 Fission-1 (Fis1),12,13 Mitochondrial fission factor GTPases.3–5 The discovery of the mitochondrial “shaping” (Mff),14 TBC1D1515 and others, and the mitochondrial fusion proteins, the “mitofusins”, further revolutionized our under- proteins include the large GTPase mitofusins (Mfn1 and Mfn2)16 standing of mitochondrial plasticity in normal and disease localized on the OMM, as well as optic atrophy 1 (OPA1)17 lo- states (reviewed by McBride and Scorrano4, Westermann6). cated on the IMM. The coordinated dynamic activation of these These proteins enable mitochondria to rapidly change mor- proteins during cell division and cell proliferation is responsible phology and complex networks within the cell through fusion for fusion and/or fission of the OMM and IMM. and fission processes. In fact, defects in mitochondrial fission/ fusion events have been identified in a number of human pa- Significance of Mitochondrial Dynamics thologies. It is not surprising that inborn genetic errors result- In addition to maintaining mitochondrial morphology, mito- ing in abnormal mitochondrial dynamics have been linked to chondrial fission/fusion events are essential for normal embry- cancer, cardiovascular disease, and neurodegenerative dis- onic growth and development. Mice germ-lines deleted for Received February 26, 2014; accepted February 26, 2014; released online March 20, 2014 Department of Physiology, Pharmacology & Therapeutics (R.D., L.A.K.), Faculty of Medicine (L.A.K.), The Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada Mailing address: Lorrie A. Kirshenbaum, PhD, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Rm 3016, 351 Taché Avenue, Winnipeg, Manitoba R2H 2A6, Canada. E-mail: [email protected] ISSN-1346-9843 doi: 10.1253/circj.CJ-14-0240 All rights are reserved to the Japanese Circulation Society. For permissions, please e-mail: [email protected] Advance Publication by-J-STAGE DHINGRA R et al. Figure 1. Regulation of mitochondrial fission. In response to fission signals, cytosolic Drp1 is recruited to mitochondria where it oligomerizes into a ring-like structure around defined sites on the mitochondrial outer membrane. Through its GTPase activity, Drp1 promotes scission of the mitochondrial membrane that progresses and results in mitochondrial fission. Mitochondrial fission may be part of the cell cycle or it may be consequent to apoptosis or autophagy depending upon the signals. Drp1 activation and inhibition is regulated by multiple signaling molecules as on the left-hand side. either of the mitochondrial fission or fusion genes are embry- inactivate its GTPases activity and fission.22,23 onically lethal, highlighting the physiological importance of In the context of the heart, myocardial ischemia-reperfusion mitochondrial dynamics in growth and development. For ex- (IR) injury remains a major cause of morbidity and mortality ample, mice lacking Drp1 have developmental abnormalities and has recently been linked to mitochondrial abnormalities in the forebrain and die at embryonic day 12.5.18 Mfn2-defec- arising from inappropriate mitochondrial fission.24,25 In this tive embryos display abnormal placental trophoblasts, with regard, HL-1 cells exposed to simulated IR displayed frag- mice lacking either of the Mfn1 or Mfn2 alleles dying mid- mented mitochondria coupled with permeability transition pore gestation.16 The link between mutations in Mfn2 and Charcot- opening and cell death that was dependent upon Drp1.25 Nota- Marie-Tooth disease further underscores the significance of bly, overexpression of, or a GTPase defective mutant of Drp1 mitochondrial fusion at the genetic level.5 This is exemplified (Drp1K38A), or mDivi, a pharmacological inhibitor of Drp1, by studies demonstrating that germ-line deletion of both Opa-1 suppressed mitochondrial fission and IR injury in HL-1 cells.26 alleles was embryonically lethal while the heterozygous Opa-1 The concept that mitochondrial fission events mediated by mice were born viable but later developed age-related retinal Drp1 are detrimental to cardiac function was further substanti- and neuronal defects.19 Hence, despite the proteins’ structural ated by in vivo studies demonstrating that the incidence of similarities, these findings demonstrate their distinct and mitochondrial fragmentation and contractile dysfunction in unique biological properties in mitochondrial fission/fusion for mouse hearts during IR was suppressed by mDivi. Taken to- normal embryonic development. gether these findings support the notion that excessive or inap- propriate mitochondrial fission during IR is detrimental.11,25 Moreover, these finding are also supported by a recent study Mitochondrial Fission demonstrating that mDivi suppressed mitochondrial fission, Drp1 is considered to be the central regulatory protein for mito- loss of mitochondrial cytochrome C and caspase activation in chondrial fission. It is localized in the cytoplasm and translocates a renal model of IR and cisplatin-induced nephrotoxicity.27 to the OMM in response to specific fission signals. Phyloge- Further inhibiting fission with a newly discovered fission in- netically, Drp1 structurally resembles the yeast ortholog Dnm1, hibitor, P110, not only inhibited mitochondrial fission but which contains a highly conserved N-terminal GTPase domain, improved mitochondrial bioenergetics and heart function after a coiled coil central domain essential for oligomerization, and ischemic injury.24 Collectively, these findings demonstrate that a C-terminal domain.20 In response to fission signals, Drp1 inappropriate mitochondrial fission mediated by Drp1 is detri- oligomerizes into ring-like structures that encompass defined mental to cardiac function under physiologically relevant con- sites on the mitochondrial OMM. Through its GTPase activity, ditions. However, Drp1-induced fission may not
Load more

Recommended publications
  • The Endocytic Membrane Trafficking Pathway Plays a Major Role
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of Liverpool Repository RESEARCH ARTICLE The Endocytic Membrane Trafficking Pathway Plays a Major Role in the Risk of Parkinson’s Disease Sara Bandres-Ciga, PhD,1,2 Sara Saez-Atienzar, PhD,3 Luis Bonet-Ponce, PhD,4 Kimberley Billingsley, MSc,1,5,6 Dan Vitale, MSc,7 Cornelis Blauwendraat, PhD,1 Jesse Raphael Gibbs, PhD,7 Lasse Pihlstrøm, MD, PhD,8 Ziv Gan-Or, MD, PhD,9,10 The International Parkinson’s Disease Genomics Consortium (IPDGC), Mark R. Cookson, PhD,4 Mike A. Nalls, PhD,1,11 and Andrew B. Singleton, PhD1* 1Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA 2Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain 3Transgenics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA 4Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA 5Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom 6Department of Pathophysiology, University of Tartu, Tartu, Estonia 7Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA 8Department of Neurology, Oslo University Hospital, Oslo, Norway 9Department of Neurology and Neurosurgery, Department of Human Genetics, McGill University, Montréal, Quebec, Canada 10Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montréal, Quebec, Canada 11Data Tecnica International, Glen Echo, Maryland, USA ABSTRACT studies, summary-data based Mendelian randomization Background: PD is a complex polygenic disorder.
    [Show full text]
  • Mitochondrial Rab Gaps Govern Autophagosome Biogenesis During Mitophagy Koji Yamano1, Adam I Fogel1, Chunxin Wang1, Alexander M Van Der Bliek2, Richard J Youle1*
    RESEARCH ARTICLE elife.elifesciences.org Mitochondrial Rab GAPs govern autophagosome biogenesis during mitophagy Koji Yamano1, Adam I Fogel1, Chunxin Wang1, Alexander M van der Bliek2, Richard J Youle1* 1Biochemistry Section, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States; 2Department of Biological Chemistry, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, United States Abstract Damaged mitochondria can be selectively eliminated by mitophagy. Although two gene products mutated in Parkinson’s disease, PINK1, and Parkin have been found to play a central role in triggering mitophagy in mammals, how the pre-autophagosomal isolation membrane selectively and accurately engulfs damaged mitochondria remains unclear. In this study, we demonstrate that TBC1D15, a mitochondrial Rab GTPase-activating protein (Rab-GAP), governs autophagosome biogenesis and morphology downstream of Parkin activation. To constrain autophagosome morphogenesis to that of the cargo, TBC1D15 inhibits Rab7 activity and associates with both the mitochondria through binding Fis1 and the isolation membrane through the interactions with LC3/ GABARAP family members. Another TBC family member TBC1D17, also participates in mitophagy and forms homodimers and heterodimers with TBC1D15. These results demonstrate that TBC1D15 and TBC1D17 mediate proper autophagic encapsulation of mitochondria by regulating Rab7 activity at the interface between mitochondria and isolation membranes. DOI: 10.7554/eLife.01612.001 *For correspondence: [email protected] Introduction Competing interests: See page 21 Autophagosomes enclose seemingly random portions of the cytoplasm to supply nutrients during starvation or they can specifically engulf cellular debris to maintain quality control (Mizushima et al., Funding: See page 21 2011).
    [Show full text]
  • Differential Redox-Regulation and Mitochondrial Dynamics in Normal and Leukemic Hematopoietic Stem Cells a Potential Window
    Critical Reviews in Oncology / Hematology 144 (2019) 102814 Contents lists available at ScienceDirect Critical Reviews in Oncology / Hematology journal homepage: www.elsevier.com/locate/critrevonc Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia T therapy ⁎ Katharina Mattes, Edo Vellenga, Hein Schepers Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands ARTICLE INFO ABSTRACT Keywords: The prognosis for many patients with acute myeloid leukemia (AML) is poor, mainly due to disease relapse HSC driven by leukemia stem cells (LSCs). Recent studies have highlighted the unique metabolic properties of LSCs, LSC which might represent opportunities for LSC-selective targeting. LSCs characteristically have low levels of re- Mitochondria active oxygen species (ROS), which apparently result from a combination of low mitochondrial activity and high ROS activity of ROS-removing pathways such as autophagy. Due to this low activity, LSCs are highly dependent on BCL-2 mitochondrial regulatory mechanisms. These include the anti-apoptotic protein BCL-2, which also has crucial Autophagy Venetoclax roles in regulating the mitochondrial membrane potential, and proteins involved in mitophagy. Here we review the different pathways that impact mitochondrial activity and redox-regulation, and highlight their relevance for the functionality of both HSCs and LSCs. Additionally, novel AML therapy strategies that are based on interference with those pathways, including the promising BCL-2 inhibitor Venetoclax, are summar- ized. 1. Introduction and scope of this review regulating ROS production and mitochondrial health. HSCs rely on glycolysis as their main energy source, which results in less oxidative Current treatment strategies for acute myeloid leukemia (AML) re- burden compared to mitochondrial oxidative phosphorylation (OX- sult in an initial reduction of leukemic blasts in the majority of patients.
    [Show full text]
  • Appoptosin Interacts with Mitochondrial Outer-Membrane Fusion Proteins and Regulates Mitochondrial Morphology
    © 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 994-1002 doi:10.1242/jcs.176792 RESEARCH ARTICLE Appoptosin interacts with mitochondrial outer-membrane fusion proteins and regulates mitochondrial morphology Cuilin Zhang1, Zhun Shi1, Lingzhi Zhang1, Zehua Zhou1, Xiaoyuan Zheng1, Guiying Liu1, Guojun Bu1, Paul E. Fraser2, Huaxi Xu1,3 and Yun-wu Zhang1,* ABSTRACT mitochondrial mobility, mitophagy, cell mitosis and apoptosis Mitochondrial morphology is regulated by fusion and fission (Youle and van der Bliek, 2012). – machinery. Impaired mitochondria dynamics cause various Mitochondrial fusion comprises two events outer-membrane diseases, including Alzheimer’s disease. Appoptosin (encoded by fusion and inner-membrane fusion. In mammalian cells, two SLC25A38) is a mitochondrial carrier protein that is located in the GTPases MFN1 and MFN2, which anchor on the outer mitochondrial inner membrane. Appoptosin overexpression causes membrane of mitochondria, are responsible for the outer- overproduction of reactive oxygen species (ROS) and caspase- membrane fusion (Chen et al., 2003; Koshiba et al., 2004). dependent apoptosis, whereas appoptosin downregulation abolishes However, compared to MFN2, MFN1 is relatively specific in β-amyloid-induced mitochondrial fragmentation and neuronal death regulating mitochondrial fusion (Shen et al., 2007). MFN1- during Alzheimer’s disease. Herein, we found that overexpression harboring mitochondria have a higher tethering efficiency than of appoptosin resulted in mitochondrial fragmentation in a manner those with MFN2, and purified MFN1 also possesses higher independent of its carrier function, ROS production or caspase GTPase activity than MFN2 (Ishihara et al., 2004). In contrast, activation. Although appoptosin did not affect levels of mitochondrial MFN2 is more tissue specific in its expression pattern than MFN1 outer-membrane fusion (MFN1 and MFN2), inner-membrane fusion (Liesa et al., 2009).
    [Show full text]
  • Mitochondrial Dynamic Abnormalities in Alzheimer's Disease Sirui Jiang Case Western Reserve University
    MITOCHONDRIAL DYNAMIC ABNORMALITIES IN ALZHEIMER’S DISEASE by SIRUI JIANG Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Dissertation Advisor: Dr. Xiongwei Zhu Department of Pathology CASE WESTERN RESERVE UNIVERSITY January 2019 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of SIRUI JIANG Candidate for the degree of Doctor of Philosophy* Dr. Shu Chen (Committee Chair) Dr. Xiongwei Zhu Dr. Xinglong Wang Dr. George Dubyak Dr. Charles Hoppel August 15, 2018 *We also certify that written approval has been obtained for any proprietary material contained therein Table of Contents Table of Contents 1 List of Figures 3 Acknowledgements 5 List of Abbreviations 7 Abstract 10 Chapter 1. Introduction 12 Introduction to Alzheimer’s Disease 13 General Information 13 Pathology 14 Pathogenesis 15 Introduction to Mitochondrial Dynamics 20 Mitochondrial Function and Neuronal Health 20 Mitochondrial Dynamics 21 Mitochondrial Dynamics and Mitochondrial Function 23 Mitochondrial Dynamics and Mitochondrial Transport 24 Mitochondrial Deficits in AD 26 Mitochondrial Dysfunction in AD 26 Aβ and Mitochondrial Dysfunction 27 Mitochondrial Dynamic Abnormalities in AD: Recent Advances 28 Conclusion 34 1 Chapter 2. Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex 36 Abstract 37 Background 39 Methods 43 Results 47 Discussion 54 Figures 60 Chapter 3. DLP1 Cleavage by Calpain in Alzheimer’s Disease 71 Abstract 72 Background 73 Methods 77 Results 80 Discussion 85 Figures 89 Chapter 4. Summary, Discussion and Future Directions 96 References 108 2 List of Figures Figure 2.1 Cre-mediated ablation of Mfn2 expression in the hippocampus and cortex of Mfn2 cKO mice 60 Figure 2.2 Quantification of DLP1 and OPA1 in cKO mice 61 Figure 2.3 Mfn2 ablation caused mitochondrial fragmentation and ultrastructural damage in the hippocampus in vivo as evidenced by electron microscopic analysis.
    [Show full text]
  • CD34+ Acute Myeloid Leukemia Cells with Low Levels of Reactive Oxygen Species Show Increased Expression of Stemness Genes and Ca
    LETTERS TO THE EDITOR relapse is frequent, especially in elderly patients. Disease + CD34 acute myeloid leukemia cells with low levels relapse is likely driven by leukemia stem cells that are not of reactive oxygen species show increased affected by chemotherapy and therefore retain their dis- expression of stemness genes and can be targeted ease-initiating properties.1 Further characterization of this by the BCL2 inhibitor venetoclax leukemia stem cell population is therefore highly rele- vant. Acute myeloid leukemia (AML) is a genetically hetero- In hematopoietic cells, the stage of differentiation and geneous disease characterized by the accumulation of metabolic properties are closely linked.2 Hematopoietic immature myeloid blasts in the bone marrow. While con- stem cells characteristically have low levels of mitochon- ventional chemotherapy usually results in initial reduc- drial oxidative metabolism and consequently low levels tion of leukemic blasts in the majority of patients, disease of reactive oxygen species (ROS), which is relevant for A B C D E F G H P=0.057 Figure 1. CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species express stemness-associated genes. (A) Gating strategy for defining isolated acute myeloid leukemia (AML) cells with low or high levels of reactive oxygen species (ROS-low and ROS-high, respectively). CD34+ isolated AML cells were stained with the fluorescence dye CellROX Deep Red and gated for cells with the 15% lowest or highest signal intensity. (B) Representative FACS plots (ROS- low: blue, ROS-high: red) and May-Grünwald Giemsa staining indicating the size of ROS-low and ROS-high CD34+ AML cells (n=4).
    [Show full text]
  • A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection
    CLINICAL RESEARCH www.jasn.org A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection Weijia Zhang,1 Zhengzi Yi,1 Karen L. Keung,2 Huimin Shang,3 Chengguo Wei,1 Paolo Cravedi,1 Zeguo Sun,1 Caixia Xi,1 Christopher Woytovich,1 Samira Farouk,1 Weiqing Huang,1 Khadija Banu,1 Lorenzo Gallon,4 Ciara N. Magee,5 Nader Najafian,5 Milagros Samaniego,6 Arjang Djamali ,7 Stephen I. Alexander,2 Ivy A. Rosales,8 Rex Neal Smith,8 Jenny Xiang,3 Evelyne Lerut,9 Dirk Kuypers,10,11 Maarten Naesens ,10,11 Philip J. O’Connell,2 Robert Colvin,8 Madhav C. Menon,1 and Barbara Murphy1 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background In kidney transplant recipients, surveillance biopsies can reveal, despite stable graft function, histologic features of acute rejection and borderline changes that are associated with undesirable graft outcomes. Noninvasive biomarkers of subclinical acute rejection are needed to avoid the risks and costs associated with repeated biopsies. Methods We examined subclinical histologic and functional changes in kidney transplant recipients from the prospective Genomics of Chronic Allograft Rejection (GoCAR) study who underwent surveillance biopsies over 2 years, identifying those with subclinical or borderline acute cellular rejection (ACR) at 3 months (ACR-3) post-transplant. We performed RNA sequencing on whole blood collected from 88 indi- viduals at the time of 3-month surveillance biopsy to identify transcripts associated with ACR-3, developed a novel sequencing-based targeted expression assay, and validated this gene signature in an independent cohort.
    [Show full text]
  • Genome-Wide Synthetic Lethal CRISPR Screen Identifies FIS1 As a Genetic Interactor of ALS-Linked C9ORF72
    bioRxiv preprint doi: https://doi.org/10.1101/778118; this version posted September 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Genome-wide synthetic lethal CRISPR screen identifies FIS1 as a genetic interactor of ALS-linked C9ORF72 Noori Chai1,2, Michael S. Haney1, Julien Couthouis1, David W. Morgens1, Alyssa Benjamin1, Kathryn Wu1,2, James Ousey1, Shirleen Fang1, Sarah Finer1, Michael C. Bassik1, Aaron D. Gitler1,* Affiliations: 1. Department of Genetics, Stanford University School of Medicine, Stanford, CA USA 2. Stanford Neurosciences Graduate Program, Stanford University School of Medicine, Stanford, CA, USA *Correspondence to: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/778118; this version posted September 21, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Abstract Mutations in the C9ORF72 gene are the most common cause of amyotrophic lateral sclerosis (ALS). Both toxic gain of function and loss of function pathogenic mechanisms have been proposed. Accruing evidence from mouse knockout studies point to a role for C9ORF72 as a regulator of immune function. To provide further insight into its cellular function, we performed a genome-wide synthetic lethal CRISPR screen in human myeloid cells lacking C9ORF72. We discovered a strong synthetic lethal genetic interaction between C9ORF72 and FIS1, which encodes a mitochondrial membrane protein involved in mitochondrial fission and mitophagy.
    [Show full text]
  • Rab7a and Mitophagosome Formation
    cells Perspective Rab7a and Mitophagosome Formation Esther Hui Na Tan 1,2 and Bor Luen Tang 1,2,* 1 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore; [email protected] 2 NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 119077, Singapore * Correspondence: [email protected]; Tel.: +65-6516-1040 Received: 16 February 2019; Accepted: 1 March 2019; Published: 8 March 2019 Abstract: The small GTPase, Rab7a, and the regulators of its GDP/GTP-binding status were shown to have roles in both endocytic membrane traffic and autophagy. Classically known to regulate endosomal retrograde transport and late endosome-lysosome fusion, earlier work has indicated a role for Rab7a in autophagosome-lysosome fusion as well as autolysosome maturation. However, as suggested by recent findings on PTEN-induced kinase 1 (PINK1)-Parkin-mediated mitophagy, Rab7a and its regulators are critical for the correct targeting of Atg9a-bearing vesicles to effect autophagosome formation around damaged mitochondria. This mitophagosome formation role for Rab7a is dependent on an intact Rab cycling process mediated by the Rab7a-specific guanine nucleotide exchange factor (GEF) and GTPase activating proteins (GAPs). Rab7a activity in this regard is also dependent on the retromer complex, as well as phosphorylation by the TRAF family-associated NF-κB activator binding kinase 1 (TBK1). Here, we discuss these recent findings and broadened perspectives on the role of the Rab7a network in PINK1-Parkin mediated mitophagy. Keywords: autophagy; mitophagy; mitophagosome; Rab7; Tre-2/Bub2/Cdc16 (TBC)1D5; TBC1D15/17; TRAF family-associated NF-κB activator binding kinase 1 (TBK1) 1.
    [Show full text]
  • The Impact of Exercise on Mitochondrial Dynamics and the Role of Drp1 in Exercise Performance and Training Adaptations in Skeletal Muscle
    Original Article The impact of exercise on mitochondrial dynamics and the role of Drp1 in exercise performance and training adaptations in skeletal muscle Timothy M. Moore 1,2, Zhenqi Zhou 2, Whitaker Cohn 3, Frode Norheim 4, Amanda J. Lin 2, Nareg Kalajian 2, Alexander R. Strumwasser 2, Kevin Cory 2, Kate Whitney 2, Theodore Ho 2, Timothy Ho 2, Joseph L. Lee 2, Daniel H. Rucker 2, Orian Shirihai 2, Alexander M. van der Bliek 5, Julian P. Whitelegge 3, Marcus M. Seldin 4, Aldons J. Lusis 4,6, Sindre Lee 7, Christian A. Drevon 7,8, Sushil K. Mahata 9,10, Lorraine P. Turcotte 1, Andrea L. Hevener 2,11,* ABSTRACT Objective: Mitochondria are organelles primarily responsible for energy production, and recent evidence indicates that alterations in size, shape, location, and quantity occur in response to fluctuations in energy supply and demand. We tested the impact of acute and chronic exercise on mitochondrial dynamics signaling and determined the impact of the mitochondrial fission regulator Dynamin related protein (Drp)1 on exercise performance and muscle adaptations to training. þ À Methods: Wildtype and muscle-specific Drp1 heterozygote (mDrp1 / ) mice, as well as dysglycemic (DG) and healthy normoglycemic men (control) performed acute and chronic exercise. The Hybrid Mouse Diversity Panel, including 100 murine strains of recombinant inbred mice, was used to identify muscle Dnm1L (encodes Drp1)-gene relationships. Results: Endurance exercise impacted all aspects of the mitochondrial life cycle, i.e. fission-fusion, biogenesis, and mitophagy. Dnm1L gene expression and Drp1Ser616 phosphorylation were markedly increased by acute exercise and declined to baseline during post-exercise recovery.
    [Show full text]
  • Twin Study of Early-Onset Major Depression Finds DNA Methylation
    bioRxiv preprint doi: https://doi.org/10.1101/422345; this version posted September 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Twin Study of Early-Onset Major Depression Finds DNA Methylation Enrichment for Neurodevelopmental Genes Roxann Roberson-Nay1,2, Aaron R. Wolen4, Dana M. Lapato2,4, Eva E. Lancaster2,4, Bradley T. Webb1,2,4, Bradley Verhulst3, John M. Hettema1,2, Timothy P. YorK2,4 1. Virginia Commonwealth University, Department of Psychiatry, Richmond, VA. 2. Virginia Commonwealth University, Virginia Institute for Psychiatric and Behavioral Genetics, Richmond, VA. 3. Department of Psychology, Michigan State University, East Lansing, MI. 4. Virginia Commonwealth University, Department of Human and Molecular Genetics, Richmond, VA. Correspondence: Roxann Roberson-Nay, Ph.D., Virginia Commonwealth University, Depart- ment of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, P.O. Box 980489, Richmond, VA 23298, Fax (804) 828-0245, email: roxann.roberson- [email protected]. bioRxiv preprint doi: https://doi.org/10.1101/422345; this version posted September 20, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Major depression (MD) is a debilitating mental health condition with peak prevalence occurring early in life. Genome-wide examination of DNA methylation (DNAm) offers an attractive comple- ment to studies of allelic risk given it can reflect the combined influence of genes and environment.
    [Show full text]
  • Mitochondrial Markers 1
    Mitochondrial Markers 1 MITOCHONDRIAL MARKERS www.ptglab.com Mitochondrial Markers 2 INTRODUCTION Mitochondria are important cellular organelles that maintain cellular energy balance, contain key regulators of cell death processes, and play a significant role in cellular oxidative stress generation and maintenance of calcium homeostasis. Links to cancer, apoptosis, autophagy, and hypoxia have brought mitochondria to the forefront of scientific studies in recent years. Knowledge of the subcellular location of a protein may reveal the potential role it plays in a variety of cellular processes. Proteintech®* offers approximately all the antibodies needed for mitochondria research. What’s Inside 3–4 Mitochondrial Markers 5 Citric Acid Cycle 6–7 Mitochondrial Respiratory Complexes 8 Mitochondrial Fission Mitochondrial Fusion 9 Mitochondrial Mediated Apoptosis 10 Mitochondrial Autophagy 11 Mitochondrial Translation Mitochondrial Protein Import 12 Contact Us *Proteintech® and the Proteintech logo are trademarks of Proteintech Group registered in the US Patent and Trademark Office. Mitochondrial Markers 3 Mitochondrial Mitochondria are composed of the inner and outer membranes, the intermembrane space, the cristae, and the matrix, and they contain Markers their own DNA separated from the nucleus. Knowledge of the subcellular location of a protein may reveal the potential role it plays in a variety of cellular processes. Colocalization with one of the organelle-specific markers listed here can confirm the subcellular location of a mitochondrial
    [Show full text]